Jantzen Beth 4
4 · APPLIED DNA SCIENCES INC · Filed Mar 27, 2023
Insider Transaction Report
Form 4
Jantzen Beth
Chief Financial Officer
Transactions
- Award
Common Stock
2023-03-23+91,667→ 91,739 total - Award
Incentive Stock Option (right to buy)
2023-03-23+98,039→ 98,039 totalExercise: $1.08Exp: 2033-03-23→ Common Stock (98,039 underlying) - Award
Non-Qualified Stock Option (right to buy)
2023-03-23+1,961→ 1,961 totalExercise: $1.08Exp: 2033-03-23→ Common Stock (1,961 underlying)
Footnotes (2)
- [F1]Represents common stock underlying restricted stock units granted to the reporting person on March 23, 2023. 100% of the restricted stock units vest upon the first anniversary of the grant date.
- [F2]The options vest 25% per year commencing on the first anniversary of the grant date.